Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
54.39%
↑ 1063% vs avg
Percentile
P100
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
-5.65%
Historical baseline
PeriodValue
Q3 202554.39%
Q2 2025-1.47%
Q1 2025-28.46%
Q4 202425.86%
Q3 20241.46%
Q2 2024-4.08%
Q1 20247.16%
Q4 2023-3.01%
Q3 2023-24.78%
Q2 2023-31.70%
Q1 20233.52%
Q4 202226.34%
Q3 2022-3.37%
Q2 2022-29.75%
Q1 202220.28%
Q4 2021-126.08%
Q3 202112.72%
Q2 2021-7.18%
Q1 2021-35.51%
Q4 20207.64%
Q3 2020-13.37%
Q2 202019.55%
Q1 20200.00%